19752-09-1

Basic information

• Product Name: 3,4-DICHLOROBENZYL ISOCYANATE
• Synonyms: TIMTEC-BB SBB006646;3,4-DICHLOROBENZYL ISOCYANATE;3,4-DICHLOROBENZYL ISOCYANATE 98%;3,4-Dichlorobenzyl isocyanate,98%;3,4-Dichlorobenzyl isocyanate, 98% 1GR;1,2-dichloro-4-(isocyanatomethyl)benzene
• CAS NO: 19752-09-1
• Molecular Formula: C₈H₅Cl₂NO
• Molecular Weight: 202.04
• Product Categories: Phenyl isocyanate&Phenyl isothiocyanate;Isocyanates;Nitrogen Compounds;Organic Building Blocks
• Mol File: 19752-09-1.mol

Chemical Properties

• Boiling Point: 282 °C(lit.)
• Flash Point: >230 °F
• Appearance: Clear colorless/Slightly Viscous Liquid
• Density: 1.375 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.0065mmHg at 25°C
• Refractive Index: n20/D 1.568(lit.)
• Storage Temp.: ?20°C
• CAS DataBase Reference: 3,4-DICHLOROBENZYL ISOCYANATE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DICHLOROBENZYL ISOCYANATE(19752-09-1)
• EPA Substance Registry System: 3,4-DICHLOROBENZYL ISOCYANATE(19752-09-1)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• RIDADR: UN 2206 6.1/PG 3
• WGK Germany: 3
• Hazardous Substances Data: 19752-09-1(Hazardous Substances Data)

Usage

Chemical Properties

clear colourless slightly viscous liquid

InChI:InChI=1/C8H5Cl2NO/c9-7-2-1-6(3-8(7)10)4-11-5-12/h1-3H,4H2

Upstream product

• 6831-55-6 2-(3,4-dichlorophenyl)acetyl chloride 
• 5807-30-7 3,4-dichlorophenyl acetic acid 
• 1805-32-9 3,4-dichlorobenzyl alcohol 
• 3218-49-3 3,4-dichloro-benzeneacetonitrile 
• 18880-04-1 3,4-dichlorobenzyl bromide 
• 102-49-8 3,4-dichlorobenzyl amine 

Downstream Products

• 91193-77-0 N-<2-Cyan-aethyl>-N'-<3,4-dichlor-benzyl>-harnstoff 
• 467443-23-8 1-[3-(3,4-dichloro-benzyl)-ureido]-cyclohexanecarboxylic acid benzyl ester 
• 467443-13-6 1-[3-(3,4-dichloro-benzyl)-ureido]-cyclohexanecarboxylic acid ethyl ester 
• 581812-77-3 4-[3-(3,4-dichlorobenzyl)ureido]indazole-1-carboxylic acid methyl ester 
• 776305-20-5 2-{2-[3-(3,4-dichloro-benzyl)-ureido]-4-methyl-pentanoylamino}-3-phenyl-propionic acid 
• 923972-28-5 (S)-2-((S)-2-(3-(3,4-dichlorobenzyl)ureido)-3-(pyridin-3-yl)propanamido)-3-methylbutanoic acid 
• 1003584-26-6 1-(3,4-dichlorobenzyl)-3-(4-(chloromethyl)thiazol-2-yl)urea 
• 923972-19-4 C₄₀H₄₉Cl₂N₉O₇S₂ 

Relevant articles and documents

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2 and L are as defined in the description.

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Synthesis, selective aldose reductase inhibitory profile and antihyperglycaemic potential of certain parabanic acid derivatives

Synthesis and aldose reductase inhibitory profile of certain parabanic acid derivatives 1a-p is described. Also, the antihyperglycaemic potential of these compounds was studied. The most active inhibitors in this series were compounds 1 g, 1p, and 1o which showed inhibitory activity, 36.6, 90 and 91% respectively, at concentration 1 × 10-4. Their IC50 were 2 × 10-6, 7.5 × 10-8 and 5 × 10-8, respectively. Compound 1o exhibited pronounced antihyperglycaemic effect.